Gilead Sciences Announces Presentation of Data from Study 409 Demonstrating Durable Anti-HIV Activity of Preveon over 48 weeks [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]
- Title
- Gilead Sciences Announces Presentation of Data from Study 409 Demonstrating Durable Anti-HIV Activity of Preveon over 48 weeks [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]
- Author
- Gilead Sciences (Firm)
- Publication
- Gilead Sciences
- 1998-07-01
- Rights/Permissions
-
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
- Subject terms
- press releases
- Series/Folder Title
- Chronological Files > 1998 > Events > International Conference on AIDS (12th : 1998 : Geneva, Switzerland) > Drug company materials
- Item type:
- press releases
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0147.006
- Cite this Item
-
"Gilead Sciences Announces Presentation of Data from Study 409 Demonstrating Durable Anti-HIV Activity of Preveon over 48 weeks [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0147.006. University of Michigan Library Digital Collections. Accessed May 11, 2025.